Phenytoin Sodium

규격

630-93-3CAS 번호

211-148-2EC 번호

sodium 5,5-diphenylimidazolidin-3-ide-2,4-dioneIUPAC 명칭

C15H11N2NaO2화학식

274.25 g/mol분자량

PHENYTOIN SODIUM; 630-93-3; 5,5-Diphenylhydantoin sodium salt; Diphenylhydantoin Sodium; Tacosal; Antisacer; Phenytoin sodium salt; Diphenylan sodium; PHENYTEK; Prompt Phenytoin Sodium; Phenytex; DTXSID2023775; Extended Phenytoin Sodium; PHENYTOIN SODIUM, PROMPT; Phenytoin sodium,prompt; Phenytoin sodium extended; Phenytoin sodium,extended; 4182431BJH; 2,4-Imidazolidinedione, 5,5-diphenyl-, monosodium salt; DTXCID803775; PHENYTOIN SODIUM, EXTENDED; Phenytoinum natricum; NSC-757274; Sodium Diphenylhydantoinate; Phenytoin sodium for injection; Phenytoin ER; RefChem:55855; Diphenylhydantoinate, Sodium; 5,5-Diphenyl-2,4-imidazolidinedione, monosodium salt; Monosodium 5,5-diphenyl-4-oxoimidazolidin-2-olate; 211-148-2; NSC8722; Sodium phenytoin; sodium 2,5-dioxo-4,4-diphenylimidazolidin-1-ide; 5,5-Diphenylhydantoin sodium; Sodium diphenylhydantoin; Dilantin sodium; MLS000554076; MFCD00069674; Diphantoine; Fenidantoin; Novodiphenyl; Aladdin; Alepsin; Cumatil; Decatona; Dihydan; Ditomed; Enkefal; Epdantoin; Epileptin; Epsolin; Eptolin; Fenigramon; Fenitron; Fenytoin; Hidantin; Phenilep; SMR000146393; Ditoin; Episar; Muldis; Fenitoin sodium; Hidantal sodium; Lepitoin sodium; Denyl sodium; Aleviatin sodium; Diphenine sodium; Epilantin-E; Fenitoina Sodica; Soluble phenytoin; Metinal Idantoina; Di-len; Dilantin Injection; Dilantin Suspension; OM-Hydantoine sodium; SDPH; sodium;5,5-diphenylimidazolidin-3-ide-2,4-dione; MLS000028562; Sodium diphenyl hydantoinate; Diphenylhydantoin sodium salt; Sodium 5,5-diphenylhydantoinate; Phenytoin, sodium salt; Sodium 5,5-diphenyl hydantoinate; SMR000058987; EINECS 211-148-2; 5,5-diphenyl-1,3-diazolidine-2,4-dione, sodium salt; fenitoinsodium; Hydantoin, 5,5-diphenyl-, sodium salt; Phenytoin sodium [USP:JAN]; Sodium 5,5-Diphenylhydantoin; Diphenylhydantoin, sodium salt; Sodium 5,5-diphenyl-2,4-imidazolidinedione; UNII-4182431BJH; Hydantoin, 5,5-diphenyl-, monosodium salt; Opera_ID_1233; MSK10317Na; SPECTRUM1500485; orb1311033; orb3141212; SCHEMBL3051683; PHENYTOIN SODIUM [VANDF]; HMS501J09; 5,5-Diphenylhydatoin sodium salt; PHENYTOIN SODIUM [MART.]; PHENYTOIN SODIUM [USP-RS]; PHENYTOIN SODIUM [WHO-DD]; PHENYTOIN SODIUM [WHO-IP]; HMS1920H10; HMS2091P14; HMS2233K24; HMS3259H11; HMS3373O11; PHENYTOIN SODIUM SALT [MI]; Tox21_302338; CCG-39219; EBC-06846; SBB012488; AKOS003273947; AKOS015951389; AKOS025310163; PHENYTOIN SODIUM [EP IMPURITY]; PHENYTOIN SODIUM [ORANGE BOOK]; NC00642; NSC 757274; PHENYTOIN SODIUM [EP MONOGRAPH]; PHENYTOIN SODIUM,PROMPT [VANDF]; PHENYTOIN SODIUM [USP MONOGRAPH]; NCGC00094758-01; NCGC00094758-02; NCGC00164434-01; NCGC00255285-01; PHENYTOIN SODIUM EXTENDED [VANDF]; PHENYTOIN SODIUM,EXTENDED [VANDF]; AS-13308; CAS-630-93-3; FD161078; ST067124; 5,5-Diphenylhydantoin sodium salt, >=99%; PHENYTOINUM NATRICUM [WHO-IP LATIN]; D1331; DIPHENYLHYDANTOIN SODIUM [GREEN BOOK]; PHENYTOIN SODIUM FOR INJECTION [JAN]; H12023; SR-05000001698; Q-201564; SR-05000001698-1; Q27258415; 2,4-Imidazolidinedione, 5,5-diphenyl-, sodium salt (1:1); Phenytoin sodium, European Pharmacopoeia (EP) Reference Standard; Phenytoin sodium, United States Pharmacopeia (USP) Reference Standard; Phenytoin sodium, Pharmaceutical Secondary Standard; Certified Reference Material동의어